Grafa News and Videos — Page 642

Organon (NYSE:OGN) announced that the US Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) for Tofidence, expanding the therapeutic indications of the drug within the competitive US biosimilars market.

Core & Main (NYSE:CNM) reported improved financial results for the first quarter of fiscal year 2026, supported by reliable infrastructure demand and active cost navigation in an otherwise mixed industrial environment.

Nvni Group (NASDAQ:NVNI) announced substantial progress toward completing its acquisition of a 51% controlling interest in the holding company operating Beyondsoft Corporation’s consulting and services business across the United States, Brazil, and Singapore.

Tecnoglass (NYSE:TLGS) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.15 per share for the second quarter of 2026.

Harrow (NASDAQ:HROW) announced the formal commercial re-launch of Verkazia, a targeted prescription therapy for vernal keratoconjunctivitis (VKC), an underdiagnosed but severe chronic allergic eye disease that primarily affects children.

Chewy (NYSE:CHWY) delivered a strong financial performance for the first quarter of fiscal year 2026, characterized by robust top-line growth and a significant increase in profitability despite a dynamic broader consumer environment.

APA Corporation (NASDAQ:APA) announced an agreement to acquire Savant Alaska for approximately $70 million in upfront cash, moving to lock down strategic midstream and field infrastructure on Alaska's eastern North Slope.

Opera (NASDAQ:OPRA) announced that its Board of Directors has declared a semi-annual cash dividend of $0.40 per share for holders of its ordinary shares and American Depositary Shares (ADSs).

Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $284.8 billion as of May 31, 2026.

J.Jill (NYSE:JILL) reported a 6% decline in net sales for the first quarter of fiscal 2026, falling to $144.4 million from $153.6 million in the year-ago period.